| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |